Cell-Free Methylated <i>PTGER4</i> and <i>SHOX2</i> Plasma DNA as a Biomarker for Therapy Monitoring and Prognosis in Advanced Stage NSCLC Patients.

Diagnostics (Basel) · 2023 · PMC10340633 · PMID 37443525

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

This difference showed a trend but was not statistically significant with a value of p = 0.058 ( Figure 5 ). 4.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.